pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›approval
approval
save

BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approval

April 30, 2025BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATEupdated 5mo ago
community read0 votes

Sponsor: NOVITIUM PHARMA. Form: CAPSULE. Route: ORAL

view source ↗
Data sources
fda approvals
last refreshed 5mo ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 8

  • approvalBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approvalDec 22, 2025 · 287d ago
  • approvalSYNALGOS-DC (ASPIRIN) — FDA approvalDec 22, 2025 · 287d ago
  • approvalBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approvalNov 21, 2024 · 683d ago
  • approvalSYNALGOS-DC (ASPIRIN) — FDA approvalNov 21, 2024 · 683d ago
  • approvalSYNALGOS-DC (ASPIRIN) — FDA approvalOct 31, 2024 · 704d ago
  • approvalBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approvalOct 23, 2024 · 712d ago
  • approvalBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approvalDec 15, 2023 · 1025d ago
  • approvalSYNALGOS-DC (ASPIRIN) — FDA approvalDec 15, 2023 · 1025d ago

same company · ±60 days · 2

  • approvalBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) — FDA approvalMay 9, 2025
  • approvalACETAZOLAMIDE: ACETAZOLAMIDE — FDA approvalMar 13, 2025

🐶 often sniffed alongside

top 8
  • tagApproval382 co-mentions · 104 sources
  • drugSYNALGOS-DC354 co-mentions · 107 sources
  • drugaspirin335 co-mentions · 107 sources
  • drugStem Cell Therapy for Coronavirus Disease 2019 (COVID-19)335 co-mentions · 107 sources
  • tagSmall Molecule191 co-mentions · 104 sources
  • drugcodeine127 co-mentions · 47 sources
  • drugPROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE127 co-mentions · 47 sources
  • drugPROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE127 co-mentions · 47 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?